I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 97 filers reported holding I MAB in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $630,821 | -64.7% | 477,895 | -20.0% | 0.00% | – |
| Q2 2023 | $1,786,148 | -7.9% | 597,374 | +6.6% | 0.00% | – |
| Q1 2023 | $1,939,000 | +59561.5% | 560,295 | -27.9% | 0.00% | – |
| Q4 2022 | $3,250 | -86.5% | 777,545 | +13161.9% | 0.00% | – |
| Q3 2022 | $24,000 | -99.1% | 5,863 | -97.6% | 0.00% | – |
| Q2 2022 | $2,813,000 | +49.2% | 248,972 | +114.4% | 0.00% | – |
| Q1 2022 | $1,886,000 | +1599.1% | 116,137 | +4842.0% | 0.00% | – |
| Q4 2021 | $111,000 | -94.2% | 2,350 | -91.1% | 0.00% | – |
| Q3 2021 | $1,905,000 | -84.9% | 26,290 | -82.5% | 0.00% | -100.0% |
| Q2 2021 | $12,618,000 | +81.8% | 150,298 | +4.9% | 0.00% | +100.0% |
| Q1 2021 | $6,942,000 | +694100.0% | 143,223 | +1193425.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.6% | 12 | -99.8% | 0.00% | – |
| Q3 2020 | $233,000 | +5725.0% | 6,061 | +4023.1% | 0.00% | – |
| Q2 2020 | $4,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |